Senior Marketing Engagement Lead, In-Market IG's

Job Description

Role

Summary:

The Senior Marketing Engagement Lead (MEL) owns portfolio-level customer engagement strategy, brand stewardship and governance across in-market IG brands and campaign waves in the LOC. The role sets quality standards for Local Campaign Blueprints, leads cross-brand prioritization, competitive readiness and performance optimization, partners with customer-facing teams to translate insights into action, coaches Marketing Engagement Leads or field partners where applicable, and represents Canada in above-LOC initiatives with International MCE colleagues — while partnering with Campaign Activation Lead(s) (Operations) to improve speed, quality, and consistency of omnichannel execution.

This role reports to the Business Unit Head, Rare.

Role

Purpose:

The Senior Marketing Engagement Lead owns local HCP engagement strategy and execution for in-market IG brands, translating central strategy, modular assets, market research, customer insights and competitive intelligence into high-quality Local Campaign Blueprints, integrated brand plans and tactical programs that maximize portfolio performance and patient impact.

At portfolio scale, the role sets engagement standards, manages cross-brand priorities, elevates omnichannel execution, strengthens KAM capability with L&D, and feeds actionable performance insights to the Business Unit Head, LOC Finance, IBU and MCE.

The role also leads commercial tender management for IGs, including commercial input into tender submissions and contract negotiations, in close partnership with cross-functional teams to support the future growth of the PDT IG business in Canada.

Key Responsibilities:

Portfolio prioritization and coherence

• Set engagement priorities across IG in-market brands/waves; manage sequencing conflicts and capacity constraints.
• Ensure consistent customer experience principles across portfolio.

Own and articulate the Canadian in-market IG portfolio vision, strategy, and annual operating plan

• Translate PDT BU and IBU priorities into locally relevant portfolio execution.
• Ensure the IG in-market portfolio marketing execution reflects Canadian market dynamics, customer needs, access considerations, and competitive opportunities.

Lead market innovation, customer insight and competitive readiness

• Identify, interpret and leverage market research, customer insights, field intelligence and competitive data to strengthen positioning, sharpen prioritization and proactively address emerging opportunities or risks.
• Develop and maintain productive relationships with KOLs, treatment centers and key external stakeholders to shape the market, support successful execution and reinforce Takeda’s leadership in rare disease.
• Lead the Canadian competitive response by partnering with customer-facing and cross-functional teams to create appropriate initiatives and support optimal execution.

Blueprint governance and quality standards

• Own blueprint templates, minimum requirements, KPI discipline, and review cadence.
• Establish readiness quality gates and drive continuous improvement in blueprinting.

Coach/develop customer-facing capability (where appropriate and dependent on the LOC structure)

• Create a community of practice and share best practices.
• Collaborate with Sales leadership and Learning & Development to recommend training content, strengthen account planning, support compliant disease-state and product education, and enable consistent field execution.

Senior stakeholder trade-offs and cross‑functional leadership

• Lead alignment with BU leadership, Sales leadership, Medical leadership.
• Ensure decisions are documented with owners, outcomes, deadlines and escalation pathways.
• Lead and integrate the cross‑functional brand team, including Medical, Market Access, Corporate Affairs, Advocacy, DD&T, Finance, Supply and other partners, ensuring aligned objectives, clear priorities and coordinated execution.

Portfolio‑level test‑and‑learn, launch readiness and lifecycle management

• Define what to test, where to scale, and what to stop.
• Convert learnings into market playbooks and standards; drive adoption.
• Lead lifecycle management planning, launch readiness for new indications or…